Action 4
Committed by:
In collaboration with other partners, continue to revise the Optimal ARV Formulary and ensure its inclusion in Essential Medicine List
World Health Organization (WHO)
Sub-action 4.1

Revise Optimal ARV Formulary relative to reflect PADO 3 discussions

WHO

Optimal formulary and limited used list were revised in June 2018 along with a policy brief on:  TRANSITIONING TO AN OPTIMAL PAEDIATRIC ARV FORMULARY: IMPLEMENTATION CONSIDERATIONS. They were included in the AIDS FREE toolkit for broad dissemination. A number of webinars have enabled dissemination and a dedicated one will be convened in early 2019.

-

WHO will work with ARV Procurement Working Group (APWG) to organize a meeting (possibly virtual) to revise the formulary. May/June 2018.

-

-

APWG to consider more frequent updates (outside of formal meetings) 

Sub-action 4.2

Ensure updated Optimal ARV Formulary is included in the Essential Medicine List

-

-

-

Milestone 4.2.1

WHO updates Essential Medecine List in line with outcomes of APWG revisions of the formulary (submissions to be made by Nov 2018; decisions in April 2019).

-

Submission for modifications of EML planned for November.

-

Sub-Actions & Milestones

Responsible

Notes

Updates

Milestone 4.1.1